Skip to main content

Shire plc (SHPG)

New York Stock Exchange Healthcare Medical - PharmaceuticalsView data quality →
56.8Fair

ValueMarkers Composite Index

Top 65%#15,627 of 44,714

DCF data not available

Piotroski
6/9
Neutral
Beneish
-2.46
Low Risk
Altman
0.59
Distress
DCF Value
-
N/A
ROIC
5.5%
Low
P/E
12.7
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Shire plc (SHPG) — VMCI valuation read

Shire plc (SHPG) carries a VMCI composite of 57/100, 7 points above the Healthcare sector median of 50. Among mid-cap names, that gap places SHPG in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The SHPG insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads SHPG trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 0.2x leaves covenant headroom, the line to track on Shire plc's next 10-Q.

SHPG rose 3.9% over the trailing 7 days, with a -21.0% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in SHPG’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.